117 related articles for article (PubMed ID: 3187893)
1. [Recent application methods of high dose-rate brachytherapy in head and neck tumors].
Busch M
Strahlenther Onkol; 1988 Oct; 164(10):610-8. PubMed ID: 3187893
[TBL] [Abstract][Full Text] [Related]
2. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
3. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
4. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
5. Advanced techniques in radiation therapy for head and neck cancers.
Mittal BB
Otolaryngol Clin North Am; 1991 Dec; 24(6):1569-83. PubMed ID: 1792085
[TBL] [Abstract][Full Text] [Related]
6. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
7. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
[TBL] [Abstract][Full Text] [Related]
8. [Initial experiences with interstitial brachycurietherapy (low dose rate I-125 seeds in carrier/vicryl and high dose rate Ir-192 afterloading system) in the palliative treatment of head and neck tumors].
Schwab W; Ries G; Handschuh K
HNO; 1986 Aug; 34(8):327-33. PubMed ID: 2428779
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy of neck metastases.
Choo R; Grimard L; Esche B; Crook J; Genest P; Odell P
J Otolaryngol; 1993 Feb; 22(1):54-7. PubMed ID: 7680385
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of low dose-rate brachytherapy combined with simultaneous mild temperature hyperthermia.
Sakurai H; Mitsuhashi N; Tamaki Y; Kurosaki H; Akimoto T; Ishikawa H; Saitoh J; Muramatsu H; Yamakawa M; Hayakawa K; Niibe H
Anticancer Res; 2001; 21(1B):679-84. PubMed ID: 11299825
[TBL] [Abstract][Full Text] [Related]
11. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
13. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
14. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies.
Grimard L; Esche B; Lamothe A; Cygler J; Spaans J
Head Neck; 2006 Oct; 28(10):888-95. PubMed ID: 16721742
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative high dose rate brachytherapy can be used to salvage patients with previously irradiated head and neck recurrences.
Nag S; Schuller DE; Rodríguez-Villalba S; Martínez-Monge R; Grecula J
Rev Med Univ Navarra; 1999; 43(2):56-61. PubMed ID: 11256004
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers.
Nag S; Koc M; Schuller DE; Tippin D; Grecula JC
Brachytherapy; 2005; 4(3):217-23. PubMed ID: 16182222
[TBL] [Abstract][Full Text] [Related]
17. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.
Mazeron JJ; Ardiet JM; Haie-Méder C; Kovács G; Levendag P; Peiffert D; Polo A; Rovirosa A; Strnad V
Radiother Oncol; 2009 May; 91(2):150-6. PubMed ID: 19329209
[TBL] [Abstract][Full Text] [Related]
18. [Initial results of high-dose-rate afterloading treatment of tumors in the head and neck region].
Brock A; Gitt HA; Pohlmann S; Prager W
Radiobiol Radiother (Berl); 1989; 30(6):515-20. PubMed ID: 2608891
[TBL] [Abstract][Full Text] [Related]
19. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
[TBL] [Abstract][Full Text] [Related]
20. [In vivo dosimetry in interstitial "low dose rate" afterloading therapy with Ir-192 seeds exemplified with head-neck tumors].
Sadat Khonsari A; Grabenbauer G; Müller RG; Säbel M
Strahlenther Onkol; 1991 Jul; 167(7):407-11. PubMed ID: 1858017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
